Thermo Fisher Scientific (TMO) Other Non-Current Assets (2009 - 2026)

Thermo Fisher Scientific has reported Other Non-Current Assets for 18 years, with the latest figure at $5.6 billion in Q2 2026.

• Other Non-Current Assets for Q2 2026 came in at $5.6 billion, up 21.69% year-over-year; the trailing twelve-month figure through Jun 2026 was $5.6 billion (up 21.69% YoY), and the FY2025 annual result was $5.9 billion, up 30.7% from the prior year.
• Other Non-Current Assets retreated to $5.6 billion in Q2 2026, from $6.0 billion in the prior quarter.
• Over five years, Other Non-Current Assets peaked at $6.0 billion in Q1 2026 and troughed at $4.0 billion in Q2 2023.
• A 5-year average of $4.6 billion and a median of $4.3 billion in 2022 frame the typical range for Other Non-Current Assets.
• The largest YoY upside for Other Non-Current Assets was 79.91% in 2022 against a maximum downside of 13.64% in 2022.
• A 5-year view of Other Non-Current Assets shows it stood at $4.0 billion in 2022, then fell by 0.2% to $4.0 billion in 2023, then grew by 12.33% to $4.5 billion in 2024, then jumped by 30.7% to $5.9 billion in 2025, then dropped by 4.34% to $5.6 billion in 2026.
• Per Business Quant data, the three most recent Other Non-Current Assets figures were $5.6 billion in Q2 2026, $6.0 billion in Q1 2026, and $5.9 billion in Q4 2025.